These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin. Keefer LM, Piron MA, De Meyts P. Diabetes Care; 1981; 4(2):209-14. PubMed ID: 7011729 [Abstract] [Full Text] [Related]
4. In vitro activity of biosynthetic human proinsulin. Receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes. Peavy DE, Abram JD, Frank BH, Duckworth WC. Diabetes; 1984 Nov; 33(11):1062-7. PubMed ID: 6389225 [Abstract] [Full Text] [Related]
7. Potency of biosynthetic human insulin determined in vitro. Fussgaenger RD, Ditschuneit HH, Martini H, Wiebauer-De Lenardis H, Etzrodt H, Thun C, Ditschuneit H, Pfeiffer EF, Enzmann F. Diabetes Care; 1981 Nov; 4(2):228-34. PubMed ID: 7011733 [Abstract] [Full Text] [Related]
8. Comparison of pancreatic human and biosynthetic human insulin with respect to their action on adipocytes and chick embryo fibroblasts. Zapf J, Froesch ER. Diabetes Care; 1981 Nov; 4(2):257-9. PubMed ID: 7011741 [Abstract] [Full Text] [Related]
9. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology. Kobayashi M, Sasaoka T, Sugibayashi M, Iwanishi M, Shigeta Y. Diabetes Res Clin Pract; 1989 Jun 20; 7(1):25-8. PubMed ID: 2666066 [Abstract] [Full Text] [Related]
19. Receptor binding and biological effect of insulin in human adipocytes. Andersen O, Gliemann J, Gammeltoft S. Diabetologia; 1977 Dec 13; 13(6):589-93. PubMed ID: 590650 [Abstract] [Full Text] [Related]